In addition, transfection of the doxorubicin-resistant MCF-7 breast cancer cells with miR-451 resulted in a decrease of MDR1 gene product, p-glycoprotein (P-gp), and increased sensitivity of MCF-7 cells to doxorubicin [26]. The gene discussed is PGP; the disease is breast carcinoma.